ASX:OAK Oakridge International (OAK) Stock Price, News & Analysis → Biotech's Best Kept Secret: Potential 46,751% Gain (From Behind the Markets) (Ad) Free OAK Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield8.55%Price TargetN/A Stock AnalysisStock Analysis Get Oakridge International alerts: Email Address Ad Behind the MarketsBiotech's Best Kept Secret: Potential 46,751% GainThe world's #1 biotech investor has been praising this stock since it was just $18.56. Even though it's rocketed 266% this year, he's now recommending a different biotech entirely!Get the name of the stock here >>> About Oakridge InternationalOakridge International Limited, together with its subsidiaries, engages in the development and distribution of nurse call hardware and software solutions for use in hospitals, aged care, disability care, and supported independent living facilities. The company was formerly known as Xped Limited and changed its name to Oakridge International Limited in April 2021. Oakridge International Limited was incorporated in 2006 and is based in Adelaide, Australia.Read More Ad Behind the MarketsBiotech's Best Kept Secret: Potential 46,751% GainThe world's #1 biotech investor has been praising this stock since it was just $18.56. Even though it's rocketed 266% this year, he's now recommending a different biotech entirely!Get the name of the stock here >>> OAK Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive OAK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oakridge International and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Health Information Services Sub-IndustryN/A Current SymbolASX:OAK CUSIPN/A CIKN/A Webxped.com PhoneN/AFaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.03) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net Margins-34.78% Pretax MarginN/A Return on Equity-41.48% Return on Assets-19.98% Debt Debt-to-Equity Ratio41.82 Current Ratio2.58 Quick RatioN/A Sales & Book Value Annual Sales$1.21 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.05 per share Price / BookN/AMiscellaneous Outstanding Shares17,600,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.25 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMr. Con Unerkov (Age 55)Executive Chairman, CEO & Interim CFO Comp: $201.87kMr. John Schultz (Age 59)Founder & Head of Engineering Mr. Christopher Wood (Age 62)Founder & CTO Comp: $136.97kMs. Julie EdwardsCompany SecretaryMr. Michael Raymond Clarke (Age 48)Consultant Comp: $30.22kKey Competitors1st GroupASX:1STAclarionNASDAQ:ACONWAlcidion GroupASX:ALCArcturis DataOTCMKTS:SSYNFArtryaASX:AYAView All CompetitorsInsidersCon UnerkovSold 599,970 sharesTotal: $43,797.81 ($0.07/share)Con UnerkovBought 2,500,000 shares on 9/1/2023Total: $200,000.00 ($0.08/share) This page (ASX:OAK) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaHow Biden has already won 2024Porter & CompanyThis unknown company solves the biggest issue with AIManward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oakridge International Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
